Dr. Nathan Jin Chung Chow , MD
Dermatology β’ Seattle, WA
11011 Meridian Ave N Ste 308
Seattle, WA 981338967
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on March 26, 2022; this date does not establish years in practice.
-
Published CMS data list 275 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Triamcinolone Acetonide β 52 prescription fills, including refills.
- Clobetasol Propionate β 43 prescription fills, including refills.
- Fluorouracil β 36 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 12 records in the table Β· Guide: How to read Medicare Part D prescriber data
-
Fewer Part D prescriptions than 65% of clinicians listed under Dermatology in Seattle, WA (2024, 87 clinicians with data). Median for this group: 404. Middle half: 194 to 708.
Fewer Part D prescriptions than 65% of clinicians listed under Dermatology in Washington (2024, 278 clinicians with data). Median for this group: 484. Middle half: 214 to 862.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part D prescriptions went from 25 in 2023 to 275 in 2024.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2023β2024.
Practice Location & Contact Primary Location
11011 Meridian Ave N Ste 308
Seattle, WA 981338967
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
Dermatology: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
306 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$79,800 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $4,535.85 across 51 records.
By nature of payment
- Food and Beverage: $2,802.21 across 47 records.
- Consulting Fee: $1,530.00 across 1 record.
- Education: $203.64 across 3 records.
Reporting-company totals (3 largest of 16)
- Incyte Corporation: $1,602.54 across 4 records.
- Sanofi and Genzyme US Companies: $1,023.75 across 12 records.
- UCB, Inc.: $597.40 across 9 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
NPI first issued
2022
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, βDoes your provider accept Medicare as full payment?β
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Compared with the same specialty in Seattle and Washington
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
Fewer Part D prescriptions than 65% of clinicians listed under Dermatology in Seattle, WA (2024, 87 clinicians with data). Median for this group: 404. Middle half: 194 to 708.
Fewer Part D prescriptions than 65% of clinicians listed under Dermatology in Washington (2024, 278 clinicians with data). Median for this group: 484. Middle half: 214 to 862.
Part D drug cost
Close to the middle for clinicians listed under Dermatology in Seattle, WA (2024, 87 clinicians with data). Median for this group: $68,797. Middle half: $8,056 to $179,815.
Close to the middle for clinicians listed under Dermatology in Washington (2024, 278 clinicians with data). Median for this group: $65,882. Middle half: $7,804 to $224,271.
120 active clinicians are listed under Dermatology with a practice address in Seattle, WA (384 in Washington).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Seattle
29.2% of these 120 clinicians have the CMS telehealth indicator.
69.2% of these 120 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 1000% from 25 in 2023 to 275 in 2024.
- 2023: 25
- 2024: 275
-
30-day fills
30-day fills increased 1031% from 27 in 2023 to 306 in 2024.
- 2023: 27
- 2024: 306
-
Part D drug cost
Part D drug cost increased 6416% from $1,225 in 2023 to $79,800 in 2024.
- 2023: $1,225
- 2024: $79,800
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $307.56 in 2023 to $4,535.85 in 2025.
- 2023: $307.56
- 2024: $736.76
- 2025: $4,535.85
Sources: CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo Β· Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 β December 31, 2025): 51 records totaling $4,535.85.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Incyte Corporation |
Consulting Fee
Cash or cash equivalent
|
β | General | $1,530.00 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $173.94 |
| UCB, Inc. |
Food and Beverage
In-kind items and services
|
Bimzelx | General | $151.52 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $140.15 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
SKYRIZI | General | $139.71 |
| UCB, Inc. |
Food and Beverage
In-kind items and services
|
Bimzelx | General | $129.10 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $126.19 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $121.83 |
| Arcutis Biotherapeutics, Inc. |
Food and Beverage
In-kind items and services
|
Zoryve | General | $107.88 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
SKYRIZI | General | $107.86 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $105.22 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $103.23 |
| Sanofi and Genzyme US Companies |
Education
In-kind items and services
|
DUPIXENT | General | $99.00 |
| Janssen Pharmaceuticals, Inc |
Education
In-kind items and services
|
TREMFYA | General | $94.99 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $92.36 |
| Arcutis Biotherapeutics, Inc. |
Food and Beverage
In-kind items and services
|
Zoryve | General | $91.55 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $89.11 |
| UCB, Inc. |
Food and Beverage
In-kind items and services
|
β | General | $83.91 |
| UCB, Inc. |
Food and Beverage
In-kind items and services
|
Bimzelx | General | $79.06 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
CIBINQO | General | $56.49 |
| UCB, Inc. |
Food and Beverage
In-kind items and services
|
Bimzelx | General | $41.51 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $41.15 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $39.78 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $39.13 |
| UCB, Inc. |
Food and Beverage
In-kind items and services
|
β | General | $39.08 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Triamcinolone Acetonide | Triamcinolone Acetonide | 52 | 1,646 | $455.61 | 35 |
| Clobetasol Propionate | Clobetasol Propionate | 43 | 1,114 | $1,394.15 | 25 |
| Fluorouracil | Fluorouracil | 36 | 1,022 | $2,284.49 | 35 |
| Ketoconazole | Ketoconazole | 24 | 720 | $295.99 | 15 |
| Clindamycin Phosphate | Clindamycin Phosphate | 20 | 765 | $1,702.37 | β |
| Valacyclovir | Valacyclovir Hcl | 20 | 431 | $474.94 | β |
| Hydrocortisone | Hydrocortisone | 19 | 407 | $90.95 | 12 |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 15 | 486 | $190.27 | β |
| Otezla | Apremilast | 13 | 390 | $71,268.49 | β |
| Metronidazole | Metronidazole | 11 | 360 | $257.33 | β |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 11 | 400 | $389.02 | β |
| Tacrolimus | Tacrolimus | 11 | 285 | $995.92 | β |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2026-07-01NUCC Taxonomy Code: 207N00000X
A dermatologist is trained to diagnose and treat pediatric and adult patients with benign and malignant disorders of the skin, mouth, external genitalia, hair and nails, as well as a number of sexually transmitted diseases. The dermatologist has had additional training and experience in the diagnosis and treatment of skin cancers, melanomas, moles and other tumors of the skin, the management of contact dermatitis and other allergic and nonallergic skin disorders, and in the recognition of the skin manifestations of systemic (including internal malignancy) and infectious diseases. Dermatologists have special training in dermatopathology and in the surgical techniques used in dermatology. They also have expertise in the management of cosmetic disorders of the skin such as hair loss and scars and the skin changes associated with aging.
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Physician Assistant - Medical
Bachelor of Arts, MHSPA
Specialist
Doctor of Medicine (M.D.)
Dermatology
Doctor of Medicine (M.D.)
Dermatology
Doctor of Medicine (M.D.)
Physician Assistant - Medical
Physician Assistant (Certified)
Dermatology - MOHS-Micrographic Surgery
Doctor of Medicine (M.D.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 11011 MERIDIAN AVE N STE 308, SEATTLE, WA 981338967 (Tel: 2068595777)
Registered at 1314 CRICKLEWOOD LN, SPRING, TX 773793654 (Tel: 8322604050)
Registered at 7165 N PIMA CANYON DR, TUCSON, AZ 857181407 (Tel: 5206948888)
Registered at 7165 N PIMA CANYON DR, TUCSON, AZ 857181407
Dermatology (license number reported to NPPES: AZ R80184)
Student in an Organized Health Care Education/Training Program (license number reported to NPPES: IL 125.080167)
NPI status registered as active in NPPES database
Registered at 3249 OAK PARK AVE, BERWYN, IL 604023429 (Tel: 8322604050)
Registered at 3249 OAK PARK AVE, BERWYN, IL 604020715
Recorded as NATHAN CHOW, MD
Student in an Organized Health Care Education/Training Program
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Dermatology Specialists in Seattle
- Dr. Erin Moore, MD
- Dr. Fan Liu, MD
- Dr. Vivian Shi, MD
- Dr. Spencer Vale, MD
- Dr. Keesha Jeter, DO
- Dr. Tien Nguyen, MD
Mailing Address
1314 Cricklewood Ln
Spring, TX 773793654
Phone: 8322604050